PATENT CLAIM ANALYSIS

Application Number: 15941089
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["424", "247100"]

Abstract:
An effective amount of botulinum toxin type B is administered to a subject in need thereof for treating Raynaud's phenomenon. Botulinum toxin type B may be in a form of an injection, and may be locally administered to a disease affected site, in a dose of 200 to 400 units per disease affected site.

Claim (Index 1):
A method of treating Raynaud's phenomenon, comprising administering an effective amount of botulinum toxin type B to a subject in need thereof.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 90.0
- Lexical Diversity: 1.51282
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['11156502', '14702269', '11329598', '15412392', '14797552']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6690263169366967
- 35 USC 102 Novelty (BERT): 0.4692071951678206
- Combined Prediction Score: 0.6490444047598092
- Mean Citation Score: 122.6304366
- Max Citation Score: 129.10692
- Similarity Product: 90.79070806483269

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test